UK study suggests Delta subvariant less likely to cause symptoms

LONDON, Nov 18 (Reuters) – A subvariant of Delta that is growing in Britain is less...

Antibody protection after mild COVID-19 may not last; an estimated 100 mln people have had long COVID

Nov 17 (Reuters) – The following is a summary of some recent studies on COVID-19. They...

Pfizer to allow generic versions of its COVID pill in 95 countries

Nov 16 (Reuters) – Pfizer Inc (PFE.N) said on Tuesday it will allow generic manufacturers to...

Fauci says boosters for all key to U.S. reaching COVID-19 endemic level

(Reuters) -Top U.S. infectious disease official Dr. Anthony Fauci said on Tuesday it is possible for...

Roche walks away from Atea partnership to develop COVID-19 pill

Nov 16 (Reuters) – Roche Holding AG (ROG.S) has ended a partnership with Atea Pharmaceuticals Inc...

AstraZeneca-Oxford COVID-19 vaccine supply hits two billion doses

Nov 16 (Reuters) – Two billion doses of the AstraZeneca-Oxford University COVID-19 vaccine have been supplied...